1-3 of 3
Teresa Obrien, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Study to Evaluate the Efficacy and Safety of Gemcitabine Combined with GMCSF and Rituximab in Heavily Pre-Treated Relapsed / Refractory B-Lymphoproliferative Disorders

Shinoj Pattali, MD, Stephanie A. Gregory, Melissa Leigh Larson, MD, Jamile M. Shammo, MD, Elena Bogdanova, CCRP, Teresa Obrien, RN, BS, Parameswaran Venugopal, MD
Journal: Blood
Blood (2011) 118 (21): 1616.
https://doi.org/10.1182/blood.V118.21.1616.1616
Published: 2011
Journal Articles

Phase II Study of 2-Weekly CHOP+Rituximab Followed by Yttrium 90 Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL).

Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Teresa Obrien, RN, Ray Drasga, MD, Robert Bayer, MD
Journal: Blood
Blood (2007) 110 (11): 4507.
https://doi.org/10.1182/blood.V110.11.4507.4507
Published: 2007
Journal Articles

Rituximab (Rituxan) Combined with ESHAP Chemotherapy Is Highly Active in Relapsed/ Refractory Aggressive Non-Hodgkin’s Lymphoma.

Parameswaran Venugopal, MD, Stephanie A. Gretory, MD, John Showel, MD, Jamile Shammo, MD, Sari Enschede, MD, Melissa Larson, MD, Teresa Obrien, RN, Tatiana D. Sokolovsky, Aaron Means
Journal: Blood
Blood (2004) 104 (11): 4636.
https://doi.org/10.1182/blood.V104.11.4636.4636
Published: 2004